Share
27 March 202023.03 The Italian Medicines Agency (Aifa) has authorized three new clinical trials on drugs for the treatment of Covid-19 disease. It is a study on 2 biological drugs (Emapalumab and Anakinra), one on a drug already in use for rheumatoid arthritis (Sarilumab) and a study with the drug Tocilizumab, also in use for arthritis, in cases early and severe.Virus, Aifa authorizes 3 studies on drugs
2020-03-27T22:15:23.745Z
23.03 The Italian Medicines Agency (Aifa) has authorized three new clinical trials on drugs for the treatment of Covid-19 disease. It is a study on 2 biological drugs (Emapalumab and Anakinra), one on a drug already in use for rheumatoid arthritis (Sarilumab) and a study with the drug Tocilizumab, also in use for arthritis, in cases early and severe.
Source: rainews